Ignite Creation Date:
2025-12-24 @ 5:30 PM
Ignite Modification Date:
2026-04-22 @ 4:48 AM
Study NCT ID:
NCT04888468
Status:
COMPLETED
Last Update Posted:
2022-03-18
First Post:
2021-05-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents
Sponsor:
Chongqing Precision Biotech Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PB01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None